Literature DB >> 22146877

Report of a Salmonella enterica serovar Typhi isolate from India producing CMY-2 AmpC β-lactamase.

Karthikeyan Kumarasamy, Padma Krishnan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22146877     DOI: 10.1093/jac/dkr514

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012.

Authors:  Rene S Hendriksen; Pimlapas Leekitcharoenphon; Oksana Lukjancenko; Chileshe Lukwesa-Musyani; Bushimbwa Tambatamba; John Mwaba; Annie Kalonda; Ruth Nakazwe; Geoffrey Kwenda; Jacob Dyring Jensen; Christina A Svendsen; Karen K Dittmann; Rolf S Kaas; Lina M Cavaco; Frank M Aarestrup; Henrik Hasman; James C L Mwansa
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  A systematic review of antimicrobial resistance of typhoidal Salmonella in India.

Authors:  Carl D Britto; Jacob John; Valsan P Verghese; Andrew J Pollard
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

3.  Antimicrobial Resistance in Salmonella Typhi Isolated From a Referral Hospital of Kathmandu, Nepal.

Authors:  Saroj Khadka; Basudha Shrestha; Anil Pokhrel; Sachin Khadka; Rajesh Dhoj Joshi; Megha Raj Banjara
Journal:  Microbiol Insights       Date:  2021-12-10

4.  Circulation of Third-Generation Cephalosporin Resistant Salmonella Typhi in Mumbai, India.

Authors:  Silvia Argimón; Geetha Nagaraj; Varun Shamanna; Dharmavaram Sravani; Ashwini Kodlipet Vasanth; Akshatha Prasanna; Aruna Poojary; Anurag Kumar Bari; Anthony Underwood; Mihir Kekre; Stephen Baker; David M Aanensen; Ravikumar Kadahalli Lingegowda
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.